Peer Review Process

FARMASAINS applies a rigorous double-blind peer-review process to ensure the scientific quality of all published articles. Each submission undergoes:

Initial screening by the Managing Editor to assess scope and suitability.

Evaluation by at least two independent reviewers with expertise in the relevant field.

Final decision by the Editor-in-Chief or an appointed academic editor.

Possible editorial decisions include Accept Submission, Revisions Required, Resubmit for Review,  or Decline Submission. Authors are provided up to four weeks to revise their manuscripts based on reviewer and editor feedback.

Ethical Standards

FARMASAINS adheres to established publishing ethics and follows the principles of COPE (Committee on Publication Ethics). All parties—authors, reviewers, and editors—must uphold:

• Integrity in research and reporting

• Avoidance of plagiarism, duplication, or data fabrication

• Transparency regarding conflicts of interest

• Confidentiality throughout the review process

• Responsible authorship and acknowledgment practices

 

Plagiarism Check

All submissions are screened for originality using Turnitin. Manuscripts containing unethical levels of similarity will not proceed to review.

 

Publication Frequency

FARMASAINS is published twice annually, in April and October.